NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Amylin Pharmaceuticals (AMLN) downgraded at Baird from Outperform to Neutral. Valuation call, based on a $28 price target.
Calgon Carbon (CCC) downgraded to hold at TheStreet Ratings.
CH Robinson (CHRW) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $65 price target. May take several quarters for the industry cycle to strengthen.Cliffs Natural (CLF) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. $60 price target. Estimates also cut, as the company is leveraged to lower iron ore prices. Coinstar (CSTR) upgraded at Canaccord from Hold to Buy. $71 price target. Company can continue to gain market share. Diamond Offshore Drilling (DO) downgraded to hold at TheStreet Ratings. Facebook (FB - Get Report) upgraded at Pivotal from Sell to Hold. Valuation call, based on a $30 price target. Finish Line (FINL) downgraded at Sterne Agee from Buy to Neutral. $25 price target. Expect anemic core growth. Fifth Third (FITB - Get Report) upgraded at Wells to Outperform, Wells Fargo said. Company can deliver solid commercial loan growth and capital returns. Flowers Foods (FLO)upgraded at SunTrust to Buy from Neutral. $28 price target. Fresh bread has stabilized. Forest Laboratories (FRX) upgraded at Leerink from Market Perform to Outperform, Leerink Swann said. Domestic portfolio deserves a premium valuation. JetBlue (JBLU) upgraded at UBS from Neutral to Buy. $8 price target. Estimates also boosted, given lower fuel prices. Masco (MAS) initiated at Wells Fargo, Outperform rating. $18-$19 valuation range. Very strong leverage to improving housing market. Owens Corning (OC) initiated at Wells Fargo, rated Outperform, Wells Fargo said. $37-$39 valuation range. Well positioned for growth in 2013. Suntrust Banks (STI - Get Report) upgraded at Wells to Outperform, Wells Fargo said. Return profile continues to improve. Ubiquiti Networks (UBNT) upgraded at Wunderlich from Hold to Buy, Wunderlich said. Valuation call, based on a $35 price target. Zynga (ZNGA) upgraded at Baird from Neutral to Outperform, Robert Baird said. $13 price target. Company is seeing slower growth and is facing a lockup expiration.